NEW YORK, September 6, 2012 /PRNewswire/ --
Dr George "Rusty" Gray II to further nurture Acta's three leading journals in the material sciences: Acta Materialia, Scripta Materialia, and Acta Biomaterialia
Acta Materialia Inc. is pleased to announce that Dr George "Rusty" Gray II has been appointed as Chairman of the Board of Governors of Acta Materialia Inc. effective immediately. He succeeds Dr William F. Scott who passed away June 25, 2012.
Rusty, a native of New York, earned his PhD from Carnegie-Mellon University in 1981 and is currently a Laboratory Fellow and staff member in the dynamic properties and constitutive modeling team within the Materials Science Division of Los Alamos National Laboratory. He has served as the TMS representative on the Acta Board of Governors since 2004.
Dr Gray said of his appointment, "I am honored and excited to serve as the Chair of the Board of Governors of Acta Materialia, Inc. and look forward to nurturing and growing the strengths represented by Acta's three journals to keep them at the forefront of the rapidly evolving research topics in materials science and engineering research."
Founded in 1953, the Acta Materialia Inc., in collaboration with Elsevier, publish three high quality journals, Acta Materialia, Scripta Materialia, and Acta Biomaterialia, which cover the areas of materials science, biomaterials, materials engineering, and materials chemistry and physics. Acta Materialia is the leading journal in its field with an impact factor of 3.755. Acta Materialia Inc. supports and promotes scientific meetings, award prizes, and undertakes other activities to further its fundamental purpose and promote the science and engineering of materials science.
"Rusty is still very active in research, is familiar with contemporary issues in materials research, and the three journals will benefit substantially from his demonstrated leadership," stated Subhash Mahajan,Coordinating Editor of the journals at Acta Materialia Inc.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).